03/28/2025
Breaking News: Expanded FDA Approval of 177Lutetium-PSMA-617
What this means for patients: Today, the therapy 177lutetium-PSMA-617 (Lu-PSMA; trade name Pluvicto®) was approved by the FDA for patients with advanced (metastatic) prostate cancer who have been treated with androgen receptor pathway inhibitor therapy. This medicine delivers a small dose of radiation attached to a molecule that specifically binds to prostate cancer. Read More
03/24/2025
Spring Salad
If you’ve been following prostate cancer-related health and wellness news for the past few years, you may have heard about the connection between plant-based diets and prostate cancer. For example, in one study, people who ate more plant-based and less animal-based foods were 47% less likely to have prostate cancer. Read More
03/21/2025
Sleep Awareness Month: Sleep is Crucial to Prostate Cancer Journey
Sleep as Medicine Did you know that March is Sleep Awareness Month? Sleeping well and long enough is crucial for well-being, especially for patients with prostate cancer and survivors. Sleep is so vital that we call it “medicine” that works in tandem with cancer treatment, healthy diet, regular exercise, and. Read More
03/20/2025
From the Prostate Cancer Research Desk: Immunotherapy Combination Shows Promise in Prostate Cancer
Combining immune checkpoint inhibitors with a targeted tumor-suppressing treatment might help patients’ own immune systems fight prostate cancer, according to new findings published in the journal Cancer Immunology Research. To multiply and spread, cancer cells must be able to escape the immune system. One way they do this is by. Read More
03/10/2025
Top 5 Takeaways for Patients from ASCO GU 2025
Thousands of clinicians and researchers gathered in February for the American Society of Clinical Oncology Genitourinary Cancers Symposium (ASCO GU). Held in San Francisco and online, the conference featured hundreds of studies of prostate cancer treatment, diagnosis, prevention, and survivorship—many led by researchers funded by PCF. For individuals with prostate. Read More
03/06/2025
New Resource for Patients: Genomic Testing to Help Inform Treatment Decisions
If you're newly diagnosed with prostate cancer, you probably have many questions, such as: How serious is my cancer? What is the risk of the cancer spreading, or coming back after treatment? What treatment should I choose? If you’ve already had a prostatectomy, you and your doctor will consider whether. Read More
02/24/2025
Bigger animals get more cancer, defying decades-old belief
Elephants, giraffes, pythons and other large species have higher cancer rates than smaller ones like mice, bats, and frogs, a new study has shown, overturning a 45-year-old belief about cancer in the animal kingdom. The research, conducted by researchers from the University of Reading, University College London and the Johns. Read More
02/20/2025
Atlanta Hawks Foundation and Ressler Gertz Family Foundation Reach New Milestone with $150,000 Donated to Fight Prostate Cancer
FOR IMMEDIATE RELEASE: 2/20/25 CONTACT: Max Strauss or Ciara Smith, Atlanta Hawks Brand Communications, [email protected] ATLANTA – Prior to tonight’s game, the Atlanta Hawks Foundation, together with the Ressler Gertz Family Foundation, announced a $150,000 donation to the Prostate Cancer Foundation (PCF) to increase awareness about prostate cancer and raise funds. Read More
02/14/2025
Thai Peanut & Quinoa Salad
If you’re a regular follower of PCF’s nutrition guidance, you know that a healthy diet can lead to many positive outcomes for patients with prostate cancer, including reducing the risk of heart disease. Dietary components recommended for good health include whole grains, lean protein, and fats such as olive oil.. Read More
02/07/2025
Healing Together: Communities, Researchers Tackle Prostate Cancer Disparities
When it comes to prostate cancer, Black communities continue to carry a heavy burden. In the U.S., one in in six Black men will develop the disease in his lifetime (versus one in eight white men). What’s more, Black patients are two to four times more likely to die. Read More